Posted On: 03/04/2015 8:45:40 AM
Post# of 30074
$AMBS anticipates initiating a 10 patient- Phase 1/2a clinical study evaluating the efficacy of #ESS in Q2, 2015 bit.ly/1xR2AcR
https://mobile.twitter.com/AmarantusBio
Trial initiation planned for Q1 2015
First Patient in early Q2 2015
http://ir.amarantus.com/all-sec-filings/conte...013699.pdf
GC
"Updates will come in shortly. Now that this ESS piece is done, focus is on to Elto IND and LymPro data presentation"
1:13pm - 26 Feb 15
https://mobile.twitter.com/g_commish
And ODD news coming up, looks to be a busy couple of weeks.
Cheers
https://mobile.twitter.com/AmarantusBio
Trial initiation planned for Q1 2015
First Patient in early Q2 2015
http://ir.amarantus.com/all-sec-filings/conte...013699.pdf
GC
"Updates will come in shortly. Now that this ESS piece is done, focus is on to Elto IND and LymPro data presentation"
1:13pm - 26 Feb 15
https://mobile.twitter.com/g_commish
And ODD news coming up, looks to be a busy couple of weeks.
Cheers
(0)
(0)
